Methodist Cancer Center - Omaha — Omaha, Nebraska

Methodist Cancer Center - Omaha is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Methodist Cancer Center - Omaha has participated in 32 clinical trials.

Therapeutic areas: Prostate Cancer, Breast Cancer, Sarcoma.

Sponsors: Radiation Therapy Oncology Group, Matrix Pharmaceutical, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Methodist Cancer Center - Omaha?

Methodist Cancer Center - Omaha has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Methodist Cancer Center - Omaha conducted?

Methodist Cancer Center - Omaha has 32 clinical trials on record. Their work covers Prostate Cancer, Breast Cancer, Sarcoma.

Is Methodist Cancer Center - Omaha accredited by Crixeo Health?

Yes — Methodist Cancer Center - Omaha holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Methodist Cancer Center - Omaha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.